For patients who are due an annual asthma review.
Please would you answer the questions on the form below and submit it to us.
If your symptoms are deteriorating or you have any concerns, please make an appointment to the respiratory nurse or a doctor as well.
Open the Asthma Annual Review Form
Now available at the practice
Fractional Exhaled Nitric Oxide (FeNO)
What is it?
FeNO devices are a novel medical technology used to aid in the diagnosis of asthma. FeNO measures fractional exhaled nitric oxide in the breath of patients. Nitric oxide is a biomarker for asthma which provides an indication of the level of inflammation in the lungs. FeNO testing produces a FeNO score which gives a value to the level of inflammation and can therefore be used to aid in the diagnosis of asthma. Although FeNO is primarily a diagnostic tool, it has an additional use in the ongoing monitoring of chronic asthma.
What are the benefits?
- FeNO can improve patient care and outcomes through aiding more accurate and effective diagnosis of asthma.
- FeNO can be used to confirm diagnosis improving misdiagnosis rates for asthma and leading to more appropriate referral to secondary care
- The possibility of using FeNO for dose adjustments and monitoring purposes could result in a reduction in inappropriate inhaler prescribing.
- The simplicity of FeNO testing means that anyone can use a FeNO device. This would reduce dependency on GPs within primary care as FeNO testing could be conducted by a practice nurse or other healthcare professional.
- FeNO increases patient understanding of their condition as they can relate to their FeNO score.
INHALERS CARBON FOOTPRINT
Did you know??
Salbutamol MDI (Metered Dose Inhaler) aerosol inhaler has a carbon footprint equivalent from Burnham to driving to Sheffield
Salbutamol DPI (Dry Powder Inhaler) has a carbon footprint of 4 miles
Speak to our Respiratory nurses to see if you can be switched